Indus Capital Partners, LLC Bei Gene, Ltd. Transaction History

Indus Capital Partners, LLC

$162 Million
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $15.6 Million - $28.6 Million	-106,153 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $22.4 Million - $35.1 Million	90,143 Added 563.04%	106,153 $28.8 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $6.88 Million - $11.1 Million	-27,568 Reduced 63.26%	16,010 $5.81 Million
Q2 2021 Aug 16, 2021	SELL	$292.75 - $367.01 $5.05 Million - $6.34 Million	-17,262 Reduced 28.37%	43,578 $15 Million
Q1 2021 May 14, 2021	SELL	$260.64 - $382.12 $11.2 Million - $16.5 Million	-43,123 Reduced 41.48%	60,840 $21.2 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $2.13 Million - $3.05 Million	9,642 Added 10.22%	103,963 $26.9 Million
Q3 2020 Nov 13, 2020	SELL	$189.18 - $286.44 $2.47 Million - $3.74 Million	-13,040 Reduced 12.15%	94,321 $27 Million
Q2 2020 Aug 13, 2020	BUY	$123.9 - $195.41 $901,496 - $1.42 Million	7,276 Added 7.27%	107,361 $20.2 Million
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $3.92 Million - $5.57 Million	-32,158 Reduced 24.32%	100,085 $12.3 Million
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $15.5 Million - $28 Million	-134,267 Reduced 50.38%	132,243 $21.9 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $32.1 Million - $39.5 Million	266,510 New	266,510 $32.6 Million
Q1 2019 May 15, 2019	SELL	$122.82 - $151.83 $17 Million - $21 Million	-138,199 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $7.31 Million - $12 Million	-68,325 Reduced 33.08%	138,199 $19.4 Million
Q3 2018 Nov 14, 2018	SELL	$152.62 - $189.66 $12.2 Million - $15.1 Million	-79,791 Reduced 27.87%	206,524 $35.6 Million
Q2 2018 Aug 14, 2018	SELL	$152.5 - $216.77 $42.4 Million - $60.2 Million	-277,774 Reduced 49.24%	286,315 $44 Million
Q1 2018 May 15, 2018	BUY	$97.41 - $177.22 $17.9 Million - $32.5 Million	183,503 Added 48.22%	564,089 $94.8 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $5.07 Million - $7.31 Million	63,751 Added 20.12%	380,586 $37.2 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $21 Million - $32.8 Million	316,835	316,835 $32.8 Million

Others Institutions Holding BGNE

# of Institutions

213

Shares Held

45.1M

Call Options Held

106K

Put Options Held

93.1K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.47 Billion
20.04% of portfolio
Capital International Investors Los Angeles, CA

7.01M
Shares

$1.64 Billion
0.21% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$1.21 Billion
19.1% of portfolio
Primecap Management CO Pasadena, CA

4.99M
Shares

$1.16 Billion
0.52% of portfolio
Baillie Gifford & CO

3.68M
Shares

$860 Million
0.42% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $24.2B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indus Capital Partners, LLC with notifications on news.

Account